Bridging the gap between therapeutic research results and physician prescribing decisions: knowledge transfer, a prerequisite to knowledge translation Jean-Pierre BoisselEmmanuel AmsallemMargaret C. Haugh Special Article 16 September 2004 Pages: 609 - 616
Impact of cytochrome P-450 inhibition by cimetidine and induction by carbamazepine on the kinetics of hypericin and pseudohypericin in healthy volunteers Andreas JohneElke S. PerloffIvar Roots Pharmacokinetics and Disposition 15 September 2004 Pages: 617 - 622
Pharmacokinetic differences between the enantiomers of lansoprazole and its metabolite, 5-hydroxylansoprazole, in relation to CYP2C19 genotypes M. MiuraH. TadaT. Suzuki Pharmacokinetics and Disposition 23 September 2004 Pages: 623 - 628
Are we going to increase the use of antidepressants up to that of benzodiazepines? Arcangelo CiunaMargherita AndrettaCorrado Barbui Pharmacoepidemiology and Prescription 23 September 2004 Pages: 629 - 634
A case control study to examine the pharmacological factors underlying ventricular septal defects in the North of England D. N. BatemanP. R. McElhattonS. H. L. Thomas Pharmacoepidemiology and Prescription 23 September 2004 Pages: 635 - 641
Whom are we treating with lipid-lowering drugs? Are we following the guidelines? Evidence from a population-based study: the Tromsø study 2001 Ingeborg HartzAnne Elise EggenInger Njølstad Pharmacoepidemiology and Prescription 29 September 2004 Pages: 643 - 649
The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals Hege Salvesen BlixKirsten K. ViktilElspeth K. Walseth Pharmacoepidemiology and Prescription 02 October 2004 Pages: 651 - 658
Drug prescription in pregnancy: analysis of a large statutory sickness fund population Veronika Egen-LappeJoerg Hasford Pharmacoepidemiology and Prescription 07 October 2004 Pages: 659 - 666
Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs Torben DybdahlMorten AndersenIvar Sønbø Kristiansen Pharmacoepidemiology and Prescription 21 October 2004 Pages: 667 - 672
Upper gastrointestinal adverse drug reactions and cyclo-oxygenase-2 inhibitors (celecoxib and rofecoxib): a case/non-case study from the French Pharmacovigilance Database S. LugardonM. Lapeyre-MestreThe French Network of Regional Pharmacovigilance Centres Pharmacoepidemiology and Prescription 23 October 2004 Pages: 673 - 677
The effects of acute ethanol intake on isoniazid pharmacokinetics R.G. DattaniF. HarryP.A. Routledge Short Communication 02 October 2004 Pages: 679 - 682
Central nervous system toxicity following topical skin application of lidocaine Tal Brosh-NissimovMerav IngbirReuven Porat Letter to the Editors 02 October 2004 Pages: 683 - 684
